Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer

David R H Christie, Christopher F. Sharpley, Vicki Bitsika

Research output: Contribution to journalArticleResearchpeer-review

34 Citations (Scopus)

Abstract

Objective The aim of this study was to review regret following treatment for localized prostate cancer, including factors associated with higher levels of regret, regret after specific treatments and the use of interventions to modify the likelihood of regret. Methods Online databases including Medline, CINAHL, EMBASE, EBSCO and PsycINFO were searched in June 2014, using the terms 'prostate' and 'regret' for publications written in English and appearing in print since the year 1997. Results Of 422 articles identified by the search criteria, 28 contained analyzable data regarding 8118 patients. The most commonly identified factors associated with regret after prostate cancer treatment were treatment toxicity factors, especially sexual and urinary function. Other factors included older age and longer time since treatment. The levels of regret were generally higher after radical prostatectomy than external beam radiotherapy or brachytherapy. Decision-making aids were the most commonly used method for reducing the likelihood of regret and were effective. Conclusions This is the first systematic review of regret following treatment for localized prostate cancer. Suggestions for the future study of regret in this setting can be made. These include the use of a standardized scale; recognizing levels of regret as low, medium or high; and separately identifying the decision made when patients have combinations of treatments such as surgery followed by radiotherapy.

Original languageEnglish
Pages (from-to)1002-1011
Number of pages10
JournalPsycho-Oncology
Volume24
Issue number9
DOIs
Publication statusPublished - 1 Sep 2015

Fingerprint

Prostatic Neoplasms
Emotions
Therapeutics
Radiotherapy
Decision Support Techniques
Brachytherapy
Prostatectomy
Publications
Prostate
Decision Making
Databases

Cite this

Christie, David R H ; Sharpley, Christopher F. ; Bitsika, Vicki. / Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer. In: Psycho-Oncology. 2015 ; Vol. 24, No. 9. pp. 1002-1011.
@article{21a335bb29c6446e96f084c236c6199e,
title = "Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer",
abstract = "Objective The aim of this study was to review regret following treatment for localized prostate cancer, including factors associated with higher levels of regret, regret after specific treatments and the use of interventions to modify the likelihood of regret. Methods Online databases including Medline, CINAHL, EMBASE, EBSCO and PsycINFO were searched in June 2014, using the terms 'prostate' and 'regret' for publications written in English and appearing in print since the year 1997. Results Of 422 articles identified by the search criteria, 28 contained analyzable data regarding 8118 patients. The most commonly identified factors associated with regret after prostate cancer treatment were treatment toxicity factors, especially sexual and urinary function. Other factors included older age and longer time since treatment. The levels of regret were generally higher after radical prostatectomy than external beam radiotherapy or brachytherapy. Decision-making aids were the most commonly used method for reducing the likelihood of regret and were effective. Conclusions This is the first systematic review of regret following treatment for localized prostate cancer. Suggestions for the future study of regret in this setting can be made. These include the use of a standardized scale; recognizing levels of regret as low, medium or high; and separately identifying the decision made when patients have combinations of treatments such as surgery followed by radiotherapy.",
author = "Christie, {David R H} and Sharpley, {Christopher F.} and Vicki Bitsika",
year = "2015",
month = "9",
day = "1",
doi = "10.1002/pon.3776",
language = "English",
volume = "24",
pages = "1002--1011",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "Wiley Blackwell (American Society Bone & Mineral Research)",
number = "9",

}

Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer. / Christie, David R H; Sharpley, Christopher F.; Bitsika, Vicki.

In: Psycho-Oncology, Vol. 24, No. 9, 01.09.2015, p. 1002-1011.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer

AU - Christie, David R H

AU - Sharpley, Christopher F.

AU - Bitsika, Vicki

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Objective The aim of this study was to review regret following treatment for localized prostate cancer, including factors associated with higher levels of regret, regret after specific treatments and the use of interventions to modify the likelihood of regret. Methods Online databases including Medline, CINAHL, EMBASE, EBSCO and PsycINFO were searched in June 2014, using the terms 'prostate' and 'regret' for publications written in English and appearing in print since the year 1997. Results Of 422 articles identified by the search criteria, 28 contained analyzable data regarding 8118 patients. The most commonly identified factors associated with regret after prostate cancer treatment were treatment toxicity factors, especially sexual and urinary function. Other factors included older age and longer time since treatment. The levels of regret were generally higher after radical prostatectomy than external beam radiotherapy or brachytherapy. Decision-making aids were the most commonly used method for reducing the likelihood of regret and were effective. Conclusions This is the first systematic review of regret following treatment for localized prostate cancer. Suggestions for the future study of regret in this setting can be made. These include the use of a standardized scale; recognizing levels of regret as low, medium or high; and separately identifying the decision made when patients have combinations of treatments such as surgery followed by radiotherapy.

AB - Objective The aim of this study was to review regret following treatment for localized prostate cancer, including factors associated with higher levels of regret, regret after specific treatments and the use of interventions to modify the likelihood of regret. Methods Online databases including Medline, CINAHL, EMBASE, EBSCO and PsycINFO were searched in June 2014, using the terms 'prostate' and 'regret' for publications written in English and appearing in print since the year 1997. Results Of 422 articles identified by the search criteria, 28 contained analyzable data regarding 8118 patients. The most commonly identified factors associated with regret after prostate cancer treatment were treatment toxicity factors, especially sexual and urinary function. Other factors included older age and longer time since treatment. The levels of regret were generally higher after radical prostatectomy than external beam radiotherapy or brachytherapy. Decision-making aids were the most commonly used method for reducing the likelihood of regret and were effective. Conclusions This is the first systematic review of regret following treatment for localized prostate cancer. Suggestions for the future study of regret in this setting can be made. These include the use of a standardized scale; recognizing levels of regret as low, medium or high; and separately identifying the decision made when patients have combinations of treatments such as surgery followed by radiotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84941091908&partnerID=8YFLogxK

U2 - 10.1002/pon.3776

DO - 10.1002/pon.3776

M3 - Article

VL - 24

SP - 1002

EP - 1011

JO - Psycho-Oncology

JF - Psycho-Oncology

SN - 1057-9249

IS - 9

ER -